Intratumoral injection bypasses the tumor’s physical defenses entirely, killing cancer cells and creating a personalized immune response that destroys solid tumors.
- Regulatory Precedents For Drug Delivery: Uncovering Clues To Successful Submissions
- Microneedle Delivery Of Telomerase Protects Skin From Radiation-Induced DNA Damage
- Benchmarking RNA Delivery Performance: Toward Standardized Metrics For Translational Success
- Rethinking Product Development Through Lipid-Based Formulations
- Overcoming Lung Tumor Barriers: Nanoparticle Delivery Strategies For Pulmonary Cancers
- Advances In Endometrial-Targeted Drug Delivery In Women's Health
- RNA Delivery Technologies: Industrial Applications And Emerging Innovations
- Why In Vivo Therapies Fail When We Treat Them Like Ex Vivo Ones
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Stability Chambers: Testing, Equipment, And Uses
Performing stability studies is a critical step in the drug development process. Discover the ways to ensure that your drug is safe and effective as it goes to market.
-
Selecting Container Closure Components: A Data-Driven Approach To CCI
Discover an efficient, data-driven process that employs innovative methods to accelerate the selection of a closure containment system that meets the requirements of the modern regulatory landscape.
-
Sophisticated Formulation Approaches For Insoluble Drug Candidates
A sophisticated drug delivery approach involves collaboration, technical experience, and years of working knowledge in drug development at different stages of the process.
-
NovaPure Stoppers - The Right Choice For Oncology Drugs
Vial containment systems with NovaPure® elastomer stoppers offer substantial performance benefits with their enhanced dimension control, reduced particle levels, inspection of every stopper, and use of FluroTec® film. Explore the performance of the film and why NovaPure stoppers should be the choice for sensitive drug products.
-
Age-Appropriate Pediatric Formulation Development
There is a significant variability in the pharmacokinetics of the same drug and dosage form between pediatric and adult populations, and the factors impacting drug bioavailability are different in children.
-
Single Source Partner: Seamless Approach To Deliver World-Class Treatment
Growing demand for high-value, complex therapies requires the right containment and delivery systems: solutions that offer superior quality and patient comfort while meeting stringent regulatory requirements.
-
A New Framework For Identifying Nitrosamine Risks And Derisking Products
Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.
-
Applying Automation To The Manufacture Of Drug Delivery Devices
Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.
-
Overcoming Limitations To Achieve Uniform Dosing
An immediate need for lower dose capsules in the clinic posed several challenges in blend formulation with very tight timelines for delivery.
-
4 Factors Affecting Solubility Of Drugs
Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects, so solubility must be evaluated in the early stages of drug discovery.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
DELIVERED BY DEGRAZIO
-
4 Opportunities For Advancing Drug Delivery
In this article, Fran DeGrazio identifies four prime opportunities for drug delivery developers to move the dial of innovation into 2026 and beyond. These avenues for advancement include diagnostics, patient tolerability, microdosing, and analytical methodologies.

